You are here

The evolution of New York City as a bioinnovation hub highlighted in new report

Three years ago, in its inaugural report on the venture capital landscapeNew York City Health Business Leaders calculated that 79 startups and growth stage companies received $703 million in 2017. To put that in a national perspective, StartUp Health ranked New York City the second most active city for health tech dealflow that year. This month, New York City Health Business Leaders’ third annual venture capital report revealed that investment has more than doubled to the tune of $2.6 billion across 117 companies for 2019. The report by NYCHBL, led by Bunny Ellerin, also spotlighted the top 100 healthcare startups in the city, highlighted investment trends, such as the growth of the digital therapeutics sector, and perspectives from venture capitalists.

Read Complete Article